Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization

Pelvic Pain Clinical Trial

Official title: Quantification of Pain Relief With Gonadal Vein Embolization for Pelvic Congestion Syndrome

Status Recruiting

Clinical Trial Summary

The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment, or poor response to treatment.

Clinical Trial Description

Chronic pelvic pain affects almost 40% of women during their lifetime. Pelvic congestion syndrome (PCS) accounts for up to 30% of those with chronic pelvic pain. The most common underlying cause of PCS is incompetence or obstruction of the gonadal veins, resulting in painful congestion of the pelvic and perineal venous vasculature. Medical treatment is first line, and aims to suppress ovarian function and induce vasoconstriction of the venous system. Unfortunately, efficacy and long-term pain relief from medical therapy is limited. Coil embolization of the gonadal veins has been shown to decrease pain in those affected by PCS, although the degree of relief has not yet been quantified. ;

Related Conditions & MeSH terms

• Pelvic Congestive Syndrome
• Pelvic Pain
• Syndrome

• NCT number: NCT03794466
• Study type: Observational
• Source: University of Kansas Medical Center
• Contact: Carissa Walter, MPH
• Phone: 9139457450
• Email: cwalter2@kumc.edu
• Status: Recruiting
• Start date: May 10, 2019
• Completion date: June 15, 2024